News

Inflammatory bowel disease, or IBD, describes Crohn’s disease and ulcerative colitis, two chronic diseases that cause inflammation in the intestines. IBD, which affects about 3 million adults in the United States, is an autoimmune disorder — a condition in which the body’s immune system attacks healthy tissues. Its symptoms include...

UC Riverside mouse study shows how gene mutation leads to ovaries failing prematurely

UC Riverside mouse study finds paternal exposure to phthalates increases risk of metabolic diseases in progeny

UC Riverside study has health implications for people living around California’s largest lake

Study provides insights into fighting broad range of pathogen’s viral strains

UC Riverside experts answer questions on Americans needing just one COVID-19 booster vaccine each year

UC Riverside experts discuss disease symptoms, vaccines, and anxiety management

UC Riverside vaccine expert David Lo shares his thoughts in a Q&A

SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants

UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts

UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed

New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders

Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells

UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines

As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...

UC Riverside mouse study focuses on the receptor TNFR1

UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome

UC Riverside-led mouse study finds a receptor greatly contributes to the harmful effects of plastic-associated chemicals

UC Riverside vaccine expert David Lo explains

Lei Stanley Qi of Stanford University will give the 2021 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside